Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110540753 | 11054075 | 3 | F | 20160623 | 20150422 | 20160706 | EXP | CA-ROCHE-1426946 | ROCHE | 0.00 | F | Y | 0.00000 | 20160706 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110540753 | 11054075 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | 150 | MG | ||||||||
| 110540753 | 11054075 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | ||||||||||
| 110540753 | 11054075 | 3 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | 0 | ||||||||||||
| 110540753 | 11054075 | 4 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 110540753 | 11054075 | 5 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 110540753 | 11054075 | 6 | C | AVAMYS | FLUTICASONE FUROATE | 1 | 0 | ||||||||||||
| 110540753 | 11054075 | 7 | C | VENTOLINE | ALBUTEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110540753 | 11054075 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110540753 | 11054075 | HO |
| 110540753 | 11054075 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110540753 | 11054075 | Asthenia | |
| 110540753 | 11054075 | Hypercalcaemia | |
| 110540753 | 11054075 | Hyperthyroidism | |
| 110540753 | 11054075 | Hypocalcaemia | |
| 110540753 | 11054075 | Hypoglycaemia | |
| 110540753 | 11054075 | Insomnia | |
| 110540753 | 11054075 | Malaise | |
| 110540753 | 11054075 | Nasopharyngitis | |
| 110540753 | 11054075 | Papillary thyroid cancer | |
| 110540753 | 11054075 | Presyncope | |
| 110540753 | 11054075 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110540753 | 11054075 | 1 | 20060908 | 0 | ||
| 110540753 | 11054075 | 2 | 20150402 | 0 |